Pharmacoeconomic evaluation of the modern nasal corticosteroids for the allergic rhinitis treatment

Journal Title: Медичні перспективи - Year 2018, Vol 23, Issue 1

Abstract

The increase of allergic rhinitis incidence is an actual problem for industrial cities. The literature data on allergic rhinitis incidence in countries of Europe and Ukraine was analyzed. According to different authors, the allergic rhinitis is registered in 12-24% of the inhabitants of the Russian Federation, 26-40% - of the USA, 24-32% - of France, 16% – of the UK, and 19% – of Denmark. There were distinguished three main clinical forms of allergic rhinitis: light, moderate and heavy. General pharmacotherapy principles of the light and moderate forms of allergic rhinitis course are presented in the current article. There were indicated medicines for the first-line therapy of allergic rhinitis group "R01AD" - the medicines acting on the respiratory system, decongestants and other drugs for topical use in diseases of the nasal cavity, corticosteroids. The assortment of nasal corticosteroids is presented by mometasone (13 trade names), beclamethasone (2 trade names), fluticasone propionate (5 trade names). It is also shown that 95.6% of the nasal corticosteroids is imported from 9 countries, mainly from India and Belgium. The Ukrainian spray Forinex produced by Pharmac is the only representative among the R01AD group, but unfortunately, according to pricing range is not a drug of choice among nasal corticosteroids. The received data testify to the risk of inclusion of only imported drugs in the insurance list and the low replacement rate by the Ukrainian drug for treatment of the allergic rhinitis.

Authors and Affiliations

A. G. Zadorozhna, O. V. Makarenko

Keywords

Related Articles

Cardio-vascular risk in patients with non-valvular persisting atrial fibrillation 

Results of cardiovascular risk factors assessment of 133 patients with persisting non-valvular atrial fibrillation (AF) (main group) being admitted for electrical cardioversion performance and comparison of these risk fa...

Анализ состояния окружающей среды техногенного региона и ее опасности для здоровья населения

Мета роботи - дати комплексну гігієнічну оцінку стану основних об'єктів екологічного середовища Донецького регіону і визначити ступінь їх потенційної небезпеки для здоров'я населення. У зв’язку з цим проведена комплексна...

Clinical and pathogenic aspects of vibrational disease and comorbid pathologies

Despite the tendency to decrease in the level of vibrational disease morbidity, this pathology is third in the structure of occupational diseases in Ukraine. According to research design, we have examined 178 vibrational...

Участь дендритних клітин у розвитку атеросклерозу вінцевих судин в експерименті

Была исследована динамика количественных и качественных изменений дендритных клеток (ДК) стенки венечных сосудов на различных этапах развития атеросклероза. Животным вводили нативные ли­попротеины низкой плотности челове...

Гастроінтестинальна стромальна пухлина великих розмірів екстрагастроінтестинальної локалізації з різними морфологічними характеристиками

Проблематика точной верификации диагноза гастроинтестинальной стромальной опухоли сегодня является актуальной по многим причинам. Так, гистологическую диагностику усложняет наличие морфологической подобности с другими ме...

Download PDF file
  • EP ID EP274799
  • DOI 10.26641/2307-0404.2018.1.124949
  • Views 109
  • Downloads 0

How To Cite

A. G. Zadorozhna, O. V. Makarenko (2018). Pharmacoeconomic evaluation of the modern nasal corticosteroids for the allergic rhinitis treatment. Медичні перспективи, 23(1), 107-112. https://europub.co.uk/articles/-A-274799